BioVaxys Technology Corp. Announces Debt Settlement Transaction
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, November 14, 2025 – BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the “Company”) announces that it has entered into debt settlement agreements with certain creditors of the Company (the “Creditors”) pursuant to which […] Continue Reading

